BNTC logo

Benitec Biopharma Inc. (BNTC)

Profile

Full Name

Benitec Biopharma Inc.

Ticker

NASDAQ: BNTC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 24, 2014

Indexes

Not included

Website

https://benitec.com

Employees

16

Key Details

Price

$12.78(-0.82%)

Market cap

$335.35M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(-100.00% YoY)

Annual EPS

-$5.51(+60.98% YoY)

PE ratio

-

Next earnings date

Sep 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $12.78
    BNTC price is $12.78

    30-Day Relative Volume

    0.98
    BNTC 30-day relative volume is 0.98

    Price Performance

    Price Today change

    -0.82%
    BNTC price is down -0.82% today

    Price YTD change

    +1.15%
    BNTC price is up +1.15% since January 1st

    Price 1-year change

    +42.58%
    BNTC price is up +42.58% year-on-year

    Price 3-year change

    +2.1%
    BNTC price is up +2.1% over the past 3 years

    Price Range

    Price All-time high

    $5916.00
    BNTC price is currently -99.78% below its historical high of $5916.00

    Price 3-year low

    $1.86
    BNTC price is currently +586.83% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $335.35M
    BNTC market capitalization is $335.35 million

    Market cap 3-year change

    +5475.68%
    BNTC market capitalization is up +5475.68% over the past 3 years

    Market cap All-time high

    $1.39B
    BNTC market capitalization is currently -75.94% below its historical high of $1.39 billion

    Market cap sector rank

    59.04%
    BNTC market capitalization is higher than 59.04% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +160.26%
    BNTC shares outstanding is up +160.26% year-on-year

    Shares Outstanding 3-Year Change

    +5360.89%
    BNTC shares outstanding is up +5360.89% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.52
    BNTC beta is 0.52

    200-day SMA

    $12.46
    BNTC price is currently +2.52% above its 200-day simple moving average

    50-day SMA

    $12.81
    BNTC price is currently -0.24% below its 50-day simple moving average

    RSI

    57.86
    BNTC 14-day relative strength index is 57.86

    Volume

    0.98
    BNTC 30-day relative volume is 0.98

    ATR

    $0.76
    BNTC average true range is $0.76

    10-day Historical Volatility

    29.63%
    BNTC 10-day historical volatility is 29.63%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    BNTC annual revenue is $0.00

    Revenue Analysts estimate

    -
    BNTC annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -100%
    BNTC annual revenue is down -100% year-on-year

    Revenue Sector rank

    28.61%
    BNTC annual revenue is higher than 28.61% of companies in Healthcare sector

    EPS

    EPS

    -$5.51
    BNTC annual earnings per share is -$5.51

    EPS Analysts estimate

    -$1.24
    BNTC annual earnings per share is currently +342.82% higher than the consensus analysts' forecast

    EPS 1-year change

    +60.98%
    BNTC annual earnings per share is up +60.98% year-on-year

    EPS Sector rank

    18.59%
    BNTC annual earnings per share is higher than 18.59% of companies in Healthcare sector

    Profit

    Gross profit

    -$343.00K
    BNTC annual gross profit is -$343.00 thousand

    Gross margin

    -
    BNTC annual gross profit margin value is unknown

    Operating profit

    -$22.60M
    BNTC annual operating income is -$22.60 million

    Operating margin

    -
    BNTC annual operating profit margin value is unknown

    Net income

    -$21.75M
    BNTC annual net profit is -$21.75 million

    Net margin

    -
    BNTC annual net profit margin value is unknown

    Expenses

    Total expenses

    $21.75M
    BNTC annual total expenses is $21.75 million

    Operating expenses

    $22.25M
    BNTC annual total operating expenses is $22.25 million

    Cost of goods sold

    $343.00K
    BNTC annual cost of goods sold is $343.00 thousand

    Selling, general & administrative expenses

    $6.99M
    BNTC annual SGA is $6.99 million

    Depreciation and amortization

    $343.00K
    BNTC annual depreciation & amortization is $343.00 thousand

    Interest expense

    $0.00
    BNTC annual interest expense is $0.00

    Income tax

    $0.00
    BNTC annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$22.60M
    BNTC annual earnings before interest & taxes is -$22.60 million

    EBITDA

    -$22.25M
    BNTC annual EBITDA is -$22.25 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $52.21M
    BNTC annual total assets is $52.21 million

    Non current assets

    $536.00K
    BNTC annual long term assets is $536.00 thousand

    Current assets

    $51.67M
    BNTC annual total current assets is $51.67 million

    Cash and cash equivalents

    $50.93M
    BNTC annual cash & cash equivalents is $50.93 million

    Accounts receivable

    $229.00K
    BNTC annual accounts receivable is $229.00 thousand

    Inventory

    $0.00
    BNTC annual inventory is $0.00

    Liabilities

    Total liabilities

    $4.96M
    BNTC annual total liabilities is $4.96 million

    Long term liabilities

    $38.00K
    BNTC annual total long term liabilities is $38.00 thousand

    Current liabilities

    $4.92M
    BNTC annual total current liabilities is $4.92 million

    Accounts payable

    $1.35M
    BNTC annual accounts payable is $1.35 million

    Debt

    Total debt

    $284.00K
    BNTC annual total debt is $284.00 thousand

    Total debt 1-year change

    -49.19%
    BNTC annual total debt is down -49.19% year-on-year

    Long term debt

    $0.00
    BNTC annual long term debt is $0.00

    Short term debt

    $284.00K
    BNTC annual short term debt is $284.00 thousand

    Equity & Capital

    Shareholders equity

    $47.25M
    BNTC annual stockholders equity is $47.25 million

    Book value

    $47.25M
    BNTC annual book value is $47.25 million

    Retained earnings

    -$190.26M
    BNTC annual retained earnings is -$190.26 million

    Working capital

    $46.75M
    BNTC annual working capital is $46.75 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$19.40M
    BNTC annual cash flow from operations is -$19.40 million

    Cash from operations 1-year change

    -7.72%
    BNTC annual cash flow from operations is down -7.72% year-on-year

    Cash from investing

    -$179.00K
    BNTC annual cash flow from investing activities is -$179.00 thousand

    Cash from investing 1-year change

    -17800%
    BNTC annual cash flow from investing activities is down -17800% year-on-year

    Cash from financing

    $68.03M
    BNTC annual cash flow from financing activities is $68.03 million

    Cash from financing 1-year change

    +324.78%
    BNTC annual cash flow from financing activities is up +324.78% year-on-year

    CAPEX

    CAPEX

    $179.00K
    BNTC annual capital expenditures is $179.00 thousand

    CAPEX 1-year change

    +17800%
    BNTC annual capital expenditures is up +17800% year-on-year

    Free Cash Flow

    Free cash flow

    -$19.58M
    BNTC annual free cash flow is -$19.58 million

    Free cash flow 1-year change

    -8.71%
    BNTC annual free cash flow is down -8.71% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    BNTC annual gross profit margin value is unknown

    Operating margin

    -
    BNTC annual operating profit margin value is unknown

    Net margin

    -
    BNTC annual net profit margin value is unknown

    ROA & ROE

    ROA

    -76.76%
    BNTC annual return on assets is -76.76%

    ROE

    -91.68%
    BNTC annual return on equity is -91.68%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BNTC price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BNTC price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.44
    BNTC price to book ratio is 3.44

    PB ratio Sector rank

    70.27%
    BNTC price to book ratio is higher than 70.27% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    BNTC price to sales ratio value is unknown

    PS ratio Sector rank

    -
    BNTC price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $232.66M
    BNTC enterprise value is $232.66 million

    Enterprise value Sector rank

    58.74%
    BNTC enterprise value is higher than 58.74% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.82
    BNTC EV/EBITDA is -7.82

    EV/EBITDA Sector rank

    15.81%
    BNTC EV/EBITDA is higher than 15.81% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.49
    BNTC annual current ratio is 10.49

    Quick ratio

    10.49
    BNTC annual quick ratio is 10.49

    Leverage

    Debt to equity

    0.01
    BNTC annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    BNTC annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    BNTC piotroski f-score value is unknown

    Altman Z-Score

    35.09
    BNTC altman z-score is 35.09

    Analyst ratings

    Recent major analysts updates

    May 19, 25 HC Wainwright & Co.
    Buy
    May 15, 25 JMP Securities
    Market Outperform
    Apr 10, 25 JMP Securities
    Market Outperform
    Mar 24, 25 HC Wainwright & Co.
    Buy
    Mar 18, 25 Citizens Capital Markets
    Market Outperform
    Feb 21, 25 HC Wainwright & Co.
    Buy
    Dec 13, 24 Baird
    Outperform
    Dec 3, 24 Guggenheim
    Buy
    Jul 22, 24 Leerink Partners
    Outperform
    Jun 13, 24 Piper Sandler
    Overweight

    Institutional Ownership

    Screeners with BNTC included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Benitec Biopharma Inc.?
    • Does Benitec Biopharma Inc. pay dividends?
    • What sector is Benitec Biopharma Inc. in?
    • What industry is Benitec Biopharma Inc. in?
    • What country is Benitec Biopharma Inc. based in?
    • When did Benitec Biopharma Inc. go public?
    • Is Benitec Biopharma Inc. in the S&P 500?
    • Is Benitec Biopharma Inc. in the NASDAQ 100?
    • Is Benitec Biopharma Inc. in the Dow Jones?
    • When was Benitec Biopharma Inc.'s last earnings report?
    • When does Benitec Biopharma Inc. report earnings?

    What is the ticker symbol for Benitec Biopharma Inc.?

    The ticker symbol for Benitec Biopharma Inc. is NASDAQ:BNTC

    Does Benitec Biopharma Inc. pay dividends?

    No, Benitec Biopharma Inc. does not pay dividends

    What sector is Benitec Biopharma Inc. in?

    Benitec Biopharma Inc. is in the Healthcare sector

    What industry is Benitec Biopharma Inc. in?

    Benitec Biopharma Inc. is in the Biotechnology industry

    What country is Benitec Biopharma Inc. based in?

    Benitec Biopharma Inc. is headquartered in United States

    When did Benitec Biopharma Inc. go public?

    Benitec Biopharma Inc.'s initial public offering (IPO) was on June 24, 2014

    Is Benitec Biopharma Inc. in the S&P 500?

    No, Benitec Biopharma Inc. is not included in the S&P 500 index

    Is Benitec Biopharma Inc. in the NASDAQ 100?

    No, Benitec Biopharma Inc. is not included in the NASDAQ 100 index

    Is Benitec Biopharma Inc. in the Dow Jones?

    No, Benitec Biopharma Inc. is not included in the Dow Jones index

    When was Benitec Biopharma Inc.'s last earnings report?

    Benitec Biopharma Inc.'s most recent earnings report was on May 14, 2025

    When does Benitec Biopharma Inc. report earnings?

    The next expected earnings date for Benitec Biopharma Inc. is September 25, 2025
    On this page